Bram Wagner to share Foundation’s insights at SLR investor advisory group workshop

The SLR investor advisory group workshop brings together investors and industry leaders to explore opportunities in developing and emerging markets. Following a kick-off session earlier this year, the workshop will address two central themes: assessing the scale of opportunities driven by growing market size, spending power, and shifting demographics, and identifying innovative business models for pharmaceutical companies to effectively capture these opportunities. 

Bram Wagner, Investment Engagement Officer at the Access to Medicine Foundation, will serve as a keynote speaker in the session “The Business Case for Global Health Equity.” His presentation will provide investment professionals with an understanding of the key findings from the 2024 Access to Medicine Index, including insights on inclusive business models adopted by pharmaceutical companies and the critical role investors play in supporting the financial sustainability of expanding access to medicine.